Patel Chirag K.

CIK 00017387011 companyBRIDGEWATER, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001738701

Recent Transactions

45 trades

Award
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-08-10+6,381,734→ 6,381,734 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2026-03-04−92,593→ 185,185 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-04$13.30/sh−37,825→ 1,393,470 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-04+92,593→ 1,431,295 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03+733,944→ 1,636,239 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03+59,931→ 917,911 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03$13.31/sh−15,616→ 902,295 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2026-03-03−733,944→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2026-03-03−59,931→ 179,795 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2026-03-03$13.31/sh−297,537→ 1,338,702 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2026-03-02+354,031→ 354,031 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2026-03-02+190,632→ 190,632 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2026-03-02+544,663→ 544,663 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-04−92,592→ 277,778 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-04$8.84/sh−47,361→ 857,980 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-04+92,592→ 905,341 total
Tax Payment
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03$8.76/sh−279,527→ 812,749 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2025-03-03+579,710→ 1,092,276 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2025-03-03−579,710→ 0 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2025-03-03+890,410→ 890,410 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2025-03-03+239,726→ 239,726 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2024-03-04+370,370→ 370,370 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2024-03-04+1,333,334→ 1,333,334 total
Other
Amneal Pharmaceuticals, Inc.$AMRX
Class B Common Stock and Common Units
2023-11-07−21,269,420→ 0 total
Other
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2023-11-07+21,269,420→ 21,269,420 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2023-03-03+733,944→ 733,944 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2022-03-03+1,159,420→ 1,159,420 total
Purchase
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2021-12-16$4.25/sh+50,000→ 512,566 total
Purchase
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2021-12-15$4.13/sh+100,000→ 462,566 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2021-03-01+926,640→ 926,640 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2020-05-07−6,459→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2020-05-07+6,459→ 362,566 total
Purchase
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2020-03-10$3.09/sh+100,000→ 356,107 total
Purchase
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2020-03-04$3.97/sh+58,938→ 256,107 total
Purchase
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2020-03-03$3.88/sh+156,421→ 197,169 total
Purchase
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2020-03-02$3.87/sh+34,641→ 40,748 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Performance-Based Restricted Stock Units
2020-02-27+1,266,490→ 1,266,490 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2019-05-08−6,107→ 0 total
Exercise/Conversion
Amneal Pharmaceuticals, Inc.$AMRX
Class A Common Stock
2019-05-08+6,107→ 6,107 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Stock Option
2019-05-06+28,044→ 28,044 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2019-05-06+6,459→ 6,459 total
Other
Amneal Pharmaceuticals, Inc.$AMRX
Class B Common Stock
2018-07-05+21,269,420→ 21,269,420 total
Other
Amneal Pharmaceuticals, Inc.$AMRX
Common Units
2018-07-05+21,269,420→ 21,269,420 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Restricted Stock Units
2018-05-07+6,107→ 6,107 total
Award
Amneal Pharmaceuticals, Inc.$AMRX
Stock Option
2018-05-07+24,977→ 24,977 total

Companies

Amneal Pharmaceuticals, Inc.
Director, President & Co-CEO
$AMRX

Recent Filings

Address

C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD

BRIDGEWATER, NJ, 08807

View on SEC.gov